Back to All
Group

Webinar: Moving beyond the hype: the reality of NGS in oncology today and in the future

25 May, 2017

Has Next Generation Sequencing lived up to the hype of industry predictions? Join our next webinar to get a unique insight into the real-world use of NGS in the clinical setting. What are the opportunities and challenges of its implementation and how will this affect future adoption and utility? This collaborative discussion between Diaceutics and NeoGenomics Laboratories will shed light on the clinical and commercial reality of NGS in oncology with predictions for what lies ahead. To attend register below.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.